| Application no. and date | 17705236.2 (espacenet) (Federated) (European Patent Register), 20170131 | | Patent/reg. no. and date | DK/EP 3411478, 20220608 | | Publication date | 20181212 | | Priority no. and date | US 201662289696 P, 20160201, US 201662409739 P, 20161018 | | EP pub. no. and date |
EP 3411478 20181212 | | Effective date | | | Applicant/owner | Bioverativ Therapeutics Inc., 225 Second Avenue
Waltham, MA 02451, US | | Applicant ref. no. | 1645751 | | Inventor | TAN, Siyuan, 53 Buckman Drive
Lexington, Massachusetts 02421, US,
LIU, Tongyao, 53 Buckman Drive
Lexington, Massachusetts 02421, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C12N 9/64 (2006.01) | | Title | OPTIMEREDE FAKTOR VIII-GENER | | Int. application no. | US2017015879 | | Int. publication no. | WO2017136358 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
